nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0347	0.109	CbGeAlD
Promethazine—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.0239	0.0624	CcSEcCtD
Promethazine—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0389	CcSEcCtD
Promethazine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0389	CcSEcCtD
Promethazine—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0389	CcSEcCtD
Promethazine—CALM1—cranial nerve—amyotrophic lateral sclerosis	0.0148	0.0467	CbGeAlD
Promethazine—CALM2—pons—amyotrophic lateral sclerosis	0.0147	0.0463	CbGeAlD
Promethazine—CALM1—pons—amyotrophic lateral sclerosis	0.0147	0.0461	CbGeAlD
Promethazine—Abscess—Riluzole—amyotrophic lateral sclerosis	0.0142	0.037	CcSEcCtD
Promethazine—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0345	CcSEcCtD
Promethazine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.013	0.034	CcSEcCtD
Promethazine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0298	CcSEcCtD
Promethazine—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0291	CcSEcCtD
Promethazine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0289	CcSEcCtD
Promethazine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0275	CcSEcCtD
Promethazine—Coma—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0268	CcSEcCtD
Promethazine—CALM2—peripheral nervous system—amyotrophic lateral sclerosis	0.0098	0.0308	CbGeAlD
Promethazine—CALM1—peripheral nervous system—amyotrophic lateral sclerosis	0.00975	0.0307	CbGeAlD
Promethazine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00963	0.0252	CcSEcCtD
Promethazine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00945	0.0247	CcSEcCtD
Promethazine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00927	0.0242	CcSEcCtD
Promethazine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00904	0.0284	CbGeAlD
Promethazine—HTR2A—pons—amyotrophic lateral sclerosis	0.00893	0.0281	CbGeAlD
Promethazine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00814	0.0213	CcSEcCtD
Promethazine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00774	0.0202	CcSEcCtD
Promethazine—CALM2—nerve—amyotrophic lateral sclerosis	0.00764	0.024	CbGeAlD
Promethazine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00762	0.024	CbGeAlD
Promethazine—CALM1—nerve—amyotrophic lateral sclerosis	0.0076	0.0239	CbGeAlD
Promethazine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00703	0.0184	CcSEcCtD
Promethazine—DRD2—nerve—amyotrophic lateral sclerosis	0.00702	0.0221	CbGeAlD
Promethazine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00653	0.0206	CbGeAlD
Promethazine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00642	0.0168	CcSEcCtD
Promethazine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00625	0.0163	CcSEcCtD
Promethazine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00611	0.016	CcSEcCtD
Promethazine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00594	0.0187	CbGeAlD
Promethazine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00585	0.0153	CcSEcCtD
Promethazine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00573	0.015	CcSEcCtD
Promethazine—CALM2—hindbrain—amyotrophic lateral sclerosis	0.00572	0.018	CbGeAlD
Promethazine—CALM1—hindbrain—amyotrophic lateral sclerosis	0.00569	0.0179	CbGeAlD
Promethazine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0056	0.0146	CcSEcCtD
Promethazine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00536	0.0169	CbGeAlD
Promethazine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00526	0.0165	CbGeAlD
Promethazine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00503	0.0131	CcSEcCtD
Promethazine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00481	0.0126	CcSEcCtD
Promethazine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00476	0.0124	CcSEcCtD
Promethazine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0123	CcSEcCtD
Promethazine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00463	0.0146	CbGeAlD
Promethazine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00459	0.012	CcSEcCtD
Promethazine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0045	0.0118	CcSEcCtD
Promethazine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0115	CcSEcCtD
Promethazine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00439	0.0115	CcSEcCtD
Promethazine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00433	0.0113	CcSEcCtD
Promethazine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0113	CcSEcCtD
Promethazine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00425	0.0111	CcSEcCtD
Promethazine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00416	0.0109	CcSEcCtD
Promethazine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00408	0.0107	CcSEcCtD
Promethazine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0105	CcSEcCtD
Promethazine—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00401	0.0126	CbGeAlD
Promethazine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.004	0.0104	CcSEcCtD
Promethazine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.004	0.0104	CcSEcCtD
Promethazine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0103	CcSEcCtD
Promethazine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0102	CcSEcCtD
Promethazine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0039	0.0102	CcSEcCtD
Promethazine—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.00387	0.0122	CbGeAlD
Promethazine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00976	CcSEcCtD
Promethazine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00945	CcSEcCtD
Promethazine—CALM2—embryo—amyotrophic lateral sclerosis	0.00358	0.0113	CbGeAlD
Promethazine—CALM1—embryo—amyotrophic lateral sclerosis	0.00356	0.0112	CbGeAlD
Promethazine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00356	0.00929	CcSEcCtD
Promethazine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.0092	CcSEcCtD
Promethazine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00908	CcSEcCtD
Promethazine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00347	0.0109	CbGeAlD
Promethazine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00901	CcSEcCtD
Promethazine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00893	CcSEcCtD
Promethazine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00893	CcSEcCtD
Promethazine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00861	CcSEcCtD
Promethazine—CALM2—brainstem—amyotrophic lateral sclerosis	0.00328	0.0103	CbGeAlD
Promethazine—CALM1—brainstem—amyotrophic lateral sclerosis	0.00326	0.0103	CbGeAlD
Promethazine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00316	0.00994	CbGeAlD
Promethazine—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00314	0.00987	CbGeAlD
Promethazine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00307	0.00967	CbGeAlD
Promethazine—CHRM4—brain—amyotrophic lateral sclerosis	0.00307	0.00965	CbGeAlD
Promethazine—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00302	0.0095	CbGeAlD
Promethazine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00301	0.00948	CbGeAlD
Promethazine—CALM3—medulla oblongata—amyotrophic lateral sclerosis	0.00291	0.00916	CbGeAlD
Promethazine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00287	0.0075	CcSEcCtD
Promethazine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00739	CcSEcCtD
Promethazine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00715	CcSEcCtD
Promethazine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00691	CcSEcCtD
Promethazine—CALM3—spinal cord—amyotrophic lateral sclerosis	0.0026	0.00817	CbGeAlD
Promethazine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00659	CcSEcCtD
Promethazine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00658	CcSEcCtD
Promethazine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00654	CcSEcCtD
Promethazine—CHRM5—brain—amyotrophic lateral sclerosis	0.0024	0.00755	CbGeAlD
Promethazine—CALM2—medulla oblongata—amyotrophic lateral sclerosis	0.00229	0.00719	CbGeAlD
Promethazine—CALM1—medulla oblongata—amyotrophic lateral sclerosis	0.00228	0.00716	CbGeAlD
Promethazine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00217	0.00682	CbGeAlD
Promethazine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00215	0.00678	CbGeAlD
Promethazine—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.00211	0.433	CrCbGaD
Promethazine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00207	0.00652	CbGeAlD
Promethazine—CALM3—cerebellum—amyotrophic lateral sclerosis	0.00206	0.00647	CbGeAlD
Promethazine—CALM2—spinal cord—amyotrophic lateral sclerosis	0.00204	0.00641	CbGeAlD
Promethazine—CALM1—spinal cord—amyotrophic lateral sclerosis	0.00203	0.00638	CbGeAlD
Promethazine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00199	0.00625	CbGeAlD
Promethazine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00196	0.00617	CbGeAlD
Promethazine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.00189	0.00594	CbGeAlD
Promethazine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00181	0.0057	CbGeAlD
Promethazine—CHRM3—nervous system—amyotrophic lateral sclerosis	0.00175	0.00552	CbGeAlD
Promethazine—CALM2—nervous system—amyotrophic lateral sclerosis	0.00172	0.0054	CbGeAlD
Promethazine—CALM1—nervous system—amyotrophic lateral sclerosis	0.00171	0.00538	CbGeAlD
Promethazine—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00169	0.00531	CbGeAlD
Promethazine—CALM3—brain—amyotrophic lateral sclerosis	0.00167	0.00526	CbGeAlD
Promethazine—CALM2—central nervous system—amyotrophic lateral sclerosis	0.00165	0.0052	CbGeAlD
Promethazine—CHRM2—brain—amyotrophic lateral sclerosis	0.00165	0.00518	CbGeAlD
Promethazine—CALM1—central nervous system—amyotrophic lateral sclerosis	0.00165	0.00518	CbGeAlD
Promethazine—Amitriptyline—SIGMAR1—amyotrophic lateral sclerosis	0.00164	0.336	CrCbGaD
Promethazine—CALM2—cerebellum—amyotrophic lateral sclerosis	0.00162	0.00508	CbGeAlD
Promethazine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00161	0.00507	CbGeAlD
Promethazine—CALM1—cerebellum—amyotrophic lateral sclerosis	0.00161	0.00506	CbGeAlD
Promethazine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00158	0.00497	CbGeAlD
Promethazine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00155	0.00488	CbGeAlD
Promethazine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00152	0.00478	CbGeAlD
Promethazine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00152	0.00477	CbGeAlD
Promethazine—CHRM1—brain—amyotrophic lateral sclerosis	0.0015	0.00471	CbGeAlD
Promethazine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00149	0.00467	CbGeAlD
Promethazine—ABCB1—embryo—amyotrophic lateral sclerosis	0.00142	0.00447	CbGeAlD
Promethazine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00139	0.00436	CbGeAlD
Promethazine—CHRM3—brain—amyotrophic lateral sclerosis	0.00134	0.00422	CbGeAlD
Promethazine—CALM2—brain—amyotrophic lateral sclerosis	0.00131	0.00413	CbGeAlD
Promethazine—CALM1—brain—amyotrophic lateral sclerosis	0.00131	0.00411	CbGeAlD
Promethazine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.00128	0.00402	CbGeAlD
Promethazine—HRH1—nervous system—amyotrophic lateral sclerosis	0.00125	0.00392	CbGeAlD
Promethazine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00124	0.00389	CbGeAlD
Promethazine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00123	0.00387	CbGeAlD
Promethazine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.00123	0.00387	CbGeAlD
Promethazine—DRD2—brain—amyotrophic lateral sclerosis	0.00121	0.0038	CbGeAlD
Promethazine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.0012	0.00378	CbGeAlD
Promethazine—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.00113	0.232	CrCbGaD
Promethazine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00104	0.00328	CbGeAlD
Promethazine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.001	0.00315	CbGeAlD
Promethazine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.00098	0.00308	CbGeAlD
Promethazine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000976	0.00307	CbGeAlD
Promethazine—HRH1—brain—amyotrophic lateral sclerosis	0.000953	0.003	CbGeAlD
Promethazine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000949	0.00298	CbGeAlD
Promethazine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000913	0.00287	CbGeAlD
Promethazine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000908	0.00286	CbGeAlD
Promethazine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000893	0.00281	CbGeAlD
Promethazine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.00081	0.00255	CbGeAlD
Promethazine—HTR2A—brain—amyotrophic lateral sclerosis	0.000796	0.0025	CbGeAlD
Promethazine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000725	0.00228	CbGeAlD
Promethazine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000683	0.00215	CbGeAlD
Promethazine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000657	0.00207	CbGeAlD
Promethazine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000642	0.00202	CbGeAlD
Promethazine—ABCB1—brain—amyotrophic lateral sclerosis	0.000522	0.00164	CbGeAlD
Promethazine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.71e-05	0.000228	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.63e-05	0.000225	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.6e-05	0.000224	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.59e-05	0.000224	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.57e-05	0.000223	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.56e-05	0.000223	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.55e-05	0.000222	CbGpPWpGaD
Promethazine—CALM3—Immune System—ATF1—amyotrophic lateral sclerosis	6.53e-05	0.000222	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.53e-05	0.000222	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—IGF1—amyotrophic lateral sclerosis	6.49e-05	0.000221	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.48e-05	0.00022	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.47e-05	0.00022	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.43e-05	0.000218	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.41e-05	0.000218	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.41e-05	0.000218	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.41e-05	0.000218	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.39e-05	0.000217	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.37e-05	0.000216	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.34e-05	0.000215	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.34e-05	0.000215	CbGpPWpGaD
Promethazine—CALM1—Immune System—ATF1—amyotrophic lateral sclerosis	6.32e-05	0.000215	CbGpPWpGaD
Promethazine—CALM2—Immune System—ATF1—amyotrophic lateral sclerosis	6.32e-05	0.000215	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.31e-05	0.000214	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.29e-05	0.000214	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—IGF1—amyotrophic lateral sclerosis	6.28e-05	0.000213	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—IGF1—amyotrophic lateral sclerosis	6.28e-05	0.000213	CbGpPWpGaD
Promethazine—CALM3—Immune System—CASP9—amyotrophic lateral sclerosis	6.22e-05	0.000211	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6.16e-05	0.000209	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.12e-05	0.000208	CbGpPWpGaD
Promethazine—CALM2—Immune System—CASP9—amyotrophic lateral sclerosis	6.02e-05	0.000205	CbGpPWpGaD
Promethazine—CALM1—Immune System—CASP9—amyotrophic lateral sclerosis	6.02e-05	0.000205	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	5.94e-05	0.000202	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.93e-05	0.000201	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.86e-05	0.000199	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.84e-05	0.000198	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.82e-05	0.000198	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.8e-05	0.000197	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.79e-05	0.000197	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.75e-05	0.000195	CbGpPWpGaD
Promethazine—CALM3—Disease—CASP9—amyotrophic lateral sclerosis	5.75e-05	0.000195	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.73e-05	0.000195	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.71e-05	0.000194	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	5.6e-05	0.00019	CbGpPWpGaD
Promethazine—CALM1—Disease—CASP9—amyotrophic lateral sclerosis	5.56e-05	0.000189	CbGpPWpGaD
Promethazine—CALM2—Disease—CASP9—amyotrophic lateral sclerosis	5.56e-05	0.000189	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	5.55e-05	0.000189	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.52e-05	0.000187	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.51e-05	0.000187	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.48e-05	0.000186	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.43e-05	0.000184	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.41e-05	0.000184	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.4e-05	0.000183	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.38e-05	0.000183	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.37e-05	0.000182	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.33e-05	0.000181	CbGpPWpGaD
Promethazine—CALM3—Immune System—ERBB4—amyotrophic lateral sclerosis	5.33e-05	0.000181	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.31e-05	0.000181	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.3e-05	0.00018	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.3e-05	0.00018	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.3e-05	0.00018	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.17e-05	0.000176	CbGpPWpGaD
Promethazine—CALM1—Immune System—ERBB4—amyotrophic lateral sclerosis	5.15e-05	0.000175	CbGpPWpGaD
Promethazine—CALM2—Immune System—ERBB4—amyotrophic lateral sclerosis	5.15e-05	0.000175	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.09e-05	0.000173	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.09e-05	0.000173	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.08e-05	0.000173	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.07e-05	0.000172	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.07e-05	0.000172	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.06e-05	0.000172	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.05e-05	0.000171	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.03e-05	0.000171	CbGpPWpGaD
Promethazine—CALM3—Immune System—CD40LG—amyotrophic lateral sclerosis	5.01e-05	0.00017	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5e-05	0.00017	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.98e-05	0.000169	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.93e-05	0.000167	CbGpPWpGaD
Promethazine—CALM3—Disease—ERBB4—amyotrophic lateral sclerosis	4.92e-05	0.000167	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.87e-05	0.000165	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.85e-05	0.000165	CbGpPWpGaD
Promethazine—CALM1—Immune System—CD40LG—amyotrophic lateral sclerosis	4.84e-05	0.000165	CbGpPWpGaD
Promethazine—CALM2—Immune System—CD40LG—amyotrophic lateral sclerosis	4.84e-05	0.000165	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.84e-05	0.000165	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.84e-05	0.000164	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.82e-05	0.000164	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.81e-05	0.000163	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.76e-05	0.000162	CbGpPWpGaD
Promethazine—CALM2—Disease—ERBB4—amyotrophic lateral sclerosis	4.76e-05	0.000162	CbGpPWpGaD
Promethazine—CALM1—Disease—ERBB4—amyotrophic lateral sclerosis	4.76e-05	0.000162	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.75e-05	0.000161	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.73e-05	0.000161	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.69e-05	0.000159	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.69e-05	0.000159	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.63e-05	0.000157	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.55e-05	0.000155	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.53e-05	0.000154	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.5e-05	0.000153	CbGpPWpGaD
Promethazine—CALM3—Immune System—C3—amyotrophic lateral sclerosis	4.43e-05	0.00015	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.36e-05	0.000148	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.36e-05	0.000148	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.33e-05	0.000147	CbGpPWpGaD
Promethazine—CALM2—Immune System—C3—amyotrophic lateral sclerosis	4.28e-05	0.000145	CbGpPWpGaD
Promethazine—CALM1—Immune System—C3—amyotrophic lateral sclerosis	4.28e-05	0.000145	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.24e-05	0.000144	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.22e-05	0.000144	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.22e-05	0.000143	CbGpPWpGaD
Promethazine—CALM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.21e-05	0.000143	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.15e-05	0.000141	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.14e-05	0.000141	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.13e-05	0.00014	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.11e-05	0.00014	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.1e-05	0.000139	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.1e-05	0.000139	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.09e-05	0.000139	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.09e-05	0.000139	CbGpPWpGaD
Promethazine—CALM2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.08e-05	0.000138	CbGpPWpGaD
Promethazine—CALM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.08e-05	0.000138	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.07e-05	0.000138	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.06e-05	0.000138	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.02e-05	0.000137	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.98e-05	0.000135	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.96e-05	0.000135	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.91e-05	0.000133	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.9e-05	0.000133	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.89e-05	0.000132	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.89e-05	0.000132	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.89e-05	0.000132	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.88e-05	0.000132	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.87e-05	0.000132	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.87e-05	0.000131	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.83e-05	0.00013	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.82e-05	0.00013	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	3.81e-05	0.000129	CbGpPWpGaD
Promethazine—CALM3—Disease—APOE—amyotrophic lateral sclerosis	3.8e-05	0.000129	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.75e-05	0.000127	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.75e-05	0.000127	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.75e-05	0.000127	CbGpPWpGaD
Promethazine—CALM2—Disease—APOE—amyotrophic lateral sclerosis	3.68e-05	0.000125	CbGpPWpGaD
Promethazine—CALM1—Disease—APOE—amyotrophic lateral sclerosis	3.68e-05	0.000125	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.5e-05	0.000119	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.47e-05	0.000118	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.45e-05	0.000117	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.44e-05	0.000117	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.44e-05	0.000117	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.44e-05	0.000117	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.43e-05	0.000116	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.42e-05	0.000116	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.38e-05	0.000115	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.38e-05	0.000115	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.33e-05	0.000113	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.33e-05	0.000113	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	3.27e-05	0.000111	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.26e-05	0.000111	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.24e-05	0.00011	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.21e-05	0.000109	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—TP53—amyotrophic lateral sclerosis	3.2e-05	0.000109	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.2e-05	0.000109	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.19e-05	0.000108	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.19e-05	0.000108	CbGpPWpGaD
Promethazine—CALM3—Metabolism—APOE—amyotrophic lateral sclerosis	3.19e-05	0.000108	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.18e-05	0.000108	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.15e-05	0.000107	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.14e-05	0.000107	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.13e-05	0.000106	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.13e-05	0.000106	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—TP53—amyotrophic lateral sclerosis	3.1e-05	0.000105	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—TP53—amyotrophic lateral sclerosis	3.1e-05	0.000105	CbGpPWpGaD
Promethazine—CALM1—Metabolism—APOE—amyotrophic lateral sclerosis	3.08e-05	0.000105	CbGpPWpGaD
Promethazine—CALM2—Metabolism—APOE—amyotrophic lateral sclerosis	3.08e-05	0.000105	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.01e-05	0.000102	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.01e-05	0.000102	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.98e-05	0.000101	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.93e-05	9.97e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.88e-05	9.8e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.86e-05	9.72e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.85e-05	9.67e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.77e-05	9.4e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.77e-05	9.4e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.77e-05	9.39e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.74e-05	9.31e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.73e-05	9.26e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.7e-05	9.16e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.66e-05	9.05e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.65e-05	9.01e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.65e-05	8.99e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.64e-05	8.96e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.63e-05	8.93e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.61e-05	8.86e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—PTGS2—amyotrophic lateral sclerosis	2.61e-05	8.86e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.6e-05	8.85e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.6e-05	8.82e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.58e-05	8.75e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.58e-05	8.75e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.56e-05	8.68e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PTGS2—amyotrophic lateral sclerosis	2.52e-05	8.57e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PTGS2—amyotrophic lateral sclerosis	2.52e-05	8.57e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.45e-05	8.31e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	2.41e-05	8.2e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.28e-05	7.73e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.26e-05	7.66e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.24e-05	7.62e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.2e-05	7.48e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.18e-05	7.42e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.13e-05	7.23e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.13e-05	7.23e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.11e-05	7.17e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.11e-05	7.17e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.07e-05	7.05e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.04e-05	6.93e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.04e-05	6.92e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.03e-05	6.9e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.02e-05	6.88e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2e-05	6.81e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2e-05	6.79e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.96e-05	6.66e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.93e-05	6.56e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.93e-05	6.55e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.92e-05	6.54e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.92e-05	6.52e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.91e-05	6.5e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.89e-05	6.43e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.89e-05	6.42e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.85e-05	6.28e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.76e-05	5.98e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.73e-05	5.88e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.73e-05	5.87e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.72e-05	5.85e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.72e-05	5.83e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.7e-05	5.78e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.7e-05	5.76e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.69e-05	5.76e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.65e-05	5.62e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.64e-05	5.57e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.64e-05	5.57e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.6e-05	5.44e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.56e-05	5.3e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.55e-05	5.26e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.55e-05	5.26e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.55e-05	5.25e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.44e-05	4.88e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.39e-05	4.73e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.39e-05	4.73e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.33e-05	4.52e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.31e-05	4.45e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.31e-05	4.44e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.3e-05	4.42e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.3e-05	4.41e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.29e-05	4.37e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.28e-05	4.35e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.09e-05	3.69e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.05e-05	3.57e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.05e-05	3.57e-05	CbGpPWpGaD
